9265.T JPX
Yamashita Health Care Holdings,Inc.
1W: -5.2%
1M: -4.0%
3M: +1.7%
YTD: +1.8%
1Y: +10.1%
3Y: +88.2%
5Y: +106.4%
¥3,565.00 ($22.59)
-30.00 (-0.83%)
Weekly Expected Move ±2.8%
¥3391
¥3493
¥3595
¥3697
¥3799
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
$617M
-29.7% ▼
5Y CAGR: -5.5%
Capital Expenditures
$279M
-262.3% ▼
5Y CAGR: +40.4%
Free Cash Flow
$338M
-57.8% ▼
5Y CAGR: -15.1%
Dividends Paid
$174M
-42.6% ▼
Buybacks
$65M
+60.6% ▲
Net Change in Cash
$398M
+175.8% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.1B | $1.0B | $635M | $580M | $616M |
| Depreciation & Amort. | $198M | $222M | $203M | $213M | $225M |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$182M | -$190M | $1.8B | $146M | -$70M |
| Other Non-Cash Items | -$156M | -$475M | -$516M | -$61M | -$154M |
| Operating Cash Flow | $912M | $581M | $2.2B | $878M | $617M |
| — Investing Activities — | |||||
| Capital Expenditures | -$146M | -$119M | -$81M | -$74M | -$310M |
| Acquisitions (Net) | -$9M | $100M | -$30M | -$605M | $339M |
| Investment Purchases | -$4M | -$334M | -$4M | -$34M | -$4M |
| Investment Sales | $8M | $300M | $1M | $44M | $0 |
| Other Investing | $17M | $25M | $7M | -$398M | -$6M |
| Investing Cash Flow | -$134M | -$28M | -$107M | -$1.1B | $19M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | -$48M | $0 |
| Stock Repurchased | -$64K | $0 | $0 | -$165M | -$65M |
| Dividends Paid | -$138M | -$230M | -$209M | -$122M | -$174M |
| Other Financing | $0 | $0 | $0 | $0 | -$1M |
| Financing Cash Flow | -$138M | -$230M | -$209M | -$335M | -$240M |
| Net Change in Cash | $640M | $324M | $1.9B | -$525M | $398M |
| Cash End of Period | $3.7B | $4.0B | $5.8B | $5.3B | $5.7B |
| Free Cash Flow | $765M | $463M | $2.1B | $801M | $338M |